Please try another search
For the six months ended 30 June 2021, GenKyoTex SArevenues was not reported. Net loss increased from EUR2.7Mto EUR5.8M. Higher net loss reflects Research andDevelopment Expense increase from EUR1M to EUR4.2M(expense), Selling/General/Admin. Expense increase fromEUR267K to EUR547K (expense), Total Financial Incomedecrease of 99% to EUR4K (income).
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Operating Income | -5.75 | -11.21 | -2.85 | -2.67 |
Net Income | -5.79 | -11.38 | -2.67 | -2.58 |
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Assets | 6.07 | 6.12 | 14.92 | 13.19 |
Total Liabilities | 4.11 | 3.47 | 2.38 | 3.35 |
Total Equity | 1.96 | 2.66 | 12.54 | 9.84 |
Period Ending: | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -4.86 | -5.71 | -1.87 | -7.59 |
Cash From Investing Activities | -0.1 | -0 | -0 | -0 |
Cash From Financing Activities | 4.87 | 4.91 | 4.55 | -0.28 |
Net Change in Cash | -0.1 | -0.8 | 2.68 | -7.88 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review